The Discounted Cash Flow (DCF) valuation of Devyser Diagnostics AB (DVYSR.ST) is (421.81) SEK. With the latest stock price at 122.00 SEK, the upside of Devyser Diagnostics AB based on DCF is -445.7%.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| WACC / Discount Rate | 5.6% - 8.0% | 6.8% |
| Long-term Growth Rate | 3.0% - 5.0% | 4.0% |
| Fair Price | (1,954.77) - (239.22) | (421.81) |
| Upside | -1702.3% - -296.1% | -445.7% |